Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
clinical trials in brazil
As a leading CRO in LATAM, we specialize in supporting clinical trials in Brazil and throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials in Brazil

Unlocking Opportunities: Why Conducting Clinical Trials in Brazil is a Smart Choice for Pharmaceutical and Biotech Companies.

Brazil has become a prime location for conducting clinical trials due to its unique characteristics and advantages for pharmaceutical and biotech companies.

These advantages include a large and diverse patient population, favorable regulatory environment, cost-effectiveness, and expertise in conducting clinical research.

In this blog post, we will explore these advantages in detail and discuss why conducting clinical trials in Brazil is a smart choice for pharmaceutical and biotech companies.

Large and Diverse Patient Population

Brazil has a population of over 200 million people, making it the fifth most populous country in the world. This large population provides a diverse patient pool for clinical trials, allowing for a broader range of patient demographics and medical conditions to be studied.

Additionally, Brazil has a high incidence of many diseases, such as cardiovascular disease, diabetes, and cancer, which are prevalent in both developed and developing countries. This makes Brazil an ideal location for clinical trials focused on these diseases.

Favorable Regulatory Environment

Brazil has a well-established regulatory framework for clinical trials, which is governed by the National Health Surveillance Agency (ANVISA). ANVISA has strict guidelines for clinical trials, which ensure the safety and well-being of study participants.

However, the regulatory process in Brazil is also streamlined, with an average approval time of around 60 days. This makes it easier for pharmaceutical and biotech companies to conduct clinical trials in Brazil, as they can quickly obtain regulatory approval to begin their studies.

Cost-Effectiveness

One of the major advantages of conducting clinical trials in Brazil is the cost-effectiveness of doing so. The cost of conducting clinical trials in Brazil is significantly lower than in other countries, such as the United States or Europe.

 This is due to several factors, including lower labor costs, lower cost of living, and favorable exchange rates.

Additionally, Brazil offers tax incentives for pharmaceutical and biotech companies that conduct clinical trials in the country, further reducing the cost of conducting trials.

clinical trials in brazil

Expertise in Conducting Clinical Research

Brazil has a well-established infrastructure for conducting clinical research, with numerous research centers and hospitals dedicated to clinical trials.

Additionally, Brazil has a large number of experienced clinical investigators and research staff who are trained in Good Clinical Practice (GCP) guidelines.

This expertise in clinical research ensures that studies are conducted to the highest standards and that data collected is accurate and reliable.

Access to Emerging Markets

Brazil is not only an important market for pharmaceutical and biotech companies but also a gateway to other emerging markets in Latin America.

Clinical trials conducted in Brazil can help companies gain access to these markets and provide valuable insights into the prevalence of diseases and treatment preferences in these regions.

This can help companies tailor their products and marketing strategies to better meet the needs of these markets.

Conclusion

Conducting clinical trials in Brazil is a smart choice for pharmaceutical and biotech companies.

Brazil offers a large and diverse patient population, a favorable regulatory environment, cost-effectiveness, expertise in conducting clinical research, and access to emerging markets.

These advantages make Brazil an attractive location for clinical trials and can help companies bring their products to market faster and more efficiently.

As a result, we can expect to see an increase in the number of clinical trials conducted in Brazil in the coming years.

Clinical Trials in Brazil

clinical trials in brazil

If you are considering conducting clinical trials in Brazil, working with a reliable and experienced contract research organization (CRO) is essential to ensure that your trials are successful. As a CRO in LATAM, Cohortias offers a wide range of services to help pharmaceutical and biotech companies navigate the clinical research landscape of the region.

Our team of experts has extensive knowledge and experience in conducting clinical trials in Brazil, as well as in other countries in Latin America. We can provide guidance and support throughout the entire clinical trial process, from protocol development to regulatory compliance and data management.

At Cohortias, we understand that each trial is unique, and we work closely with our clients to develop customized solutions that meet their specific needs and objectives. Our goal is to help our clients achieve their clinical trial goals efficiently and cost-effectively, while maintaining the highest level of quality and compliance.

So if you’re looking for a reliable and experienced partner for your clinical trials in Brazil, contact Cohortias today. Our team is ready to help you navigate the clinical research landscape of Latin America and ensure the success of your trials.

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials in Brazil

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials in Brazil

The Cohortias Team

Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials in Brazil

Network & Partnerships